Skip to main content
. Author manuscript; available in PMC: 2013 Jul 1.
Published in final edited form as: J Dermatol. 2012 Apr 9;39(7):617–624. doi: 10.1111/j.1346-8138.2012.01553.x

Figure 4. Doxorubicin treatment increases expression of mir-145 and decreases expression of OCT4 in NTERA-2 cells.

Figure 4

NTERA-2 cells, which continually express OCT4, were treated for 16 hours with the indicated doses of doxorubicin, then examined for expression of mir-145 and OCT4 mRNA by qPCR. Expression levels were normalized to untreated NTERA-2 cells, which were arbitrarily set at 1.0. Note, with increasing doses of doxorubicin, mir-145 expression levels increase with a concomitant decrease in OCT4 expression levels. n = 3 for each group.